Application 017588

Type
NDA
Sponsor
CORDEN PHARMA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GLEOSTINELOMUSTINECAPSULE;ORAL10MGYesNo
002GLEOSTINELOMUSTINECAPSULE;ORAL40MGYesNo
003GLEOSTINELOMUSTINECAPSULE;ORAL100MGYesYes
004GLEOSTINELOMUSTINECAPSULE;ORAL5MGYesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N017588-001GLEOSTINELOMUSTINE10MGCAPSULE / ORALABRLD, Approved before 1982
N017588-002GLEOSTINELOMUSTINE40MGCAPSULE / ORALABRLD, RS, Approved before 1982
N017588-003GLEOSTINELOMUSTINE100MGCAPSULE / ORALABRLD, Approved before 1982
N017588-004GLEOSTINELOMUSTINE5MGCAPSULE / ORALRLD2014-12-19

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
N017588-001AB
N017588-002AB
N017588-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 5 of 5 · 180 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N017588-001GLEOSTINE10MGCAPSULE / ORALRLD, Approved before 19823a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N017588-002GLEOSTINE40MGCAPSULE / ORALRLD, Approved before 19823a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N017588-003GLEOSTINE100MGCAPSULE / ORALRLD, RS, Approved before 19823a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-193a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N017588-001GLEOSTINE10MGCAPSULE / ORALRLD, Approved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N017588-002GLEOSTINE40MGCAPSULE / ORALRLD, Approved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N017588-003GLEOSTINE100MGCAPSULE / ORALRLD, RS, Approved before 1982f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-19f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N017588-001GLEOSTINE10MGCAPSULE / ORALRLD, Approved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09N017588-002GLEOSTINE40MGCAPSULE / ORALRLD, Approved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09N017588-003GLEOSTINE100MGCAPSULE / ORALRLD, RS, Approved before 1982e64feba35796…
2022-09-29 23:25 UTC2022-09N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-19e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N017588-001GLEOSTINE10MGCAPSULE / ORALRLD, Approved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N017588-002GLEOSTINE40MGCAPSULE / ORALRLD, Approved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N017588-003GLEOSTINE100MGCAPSULE / ORALRLD, RS, Approved before 1982cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-19cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N017588-001GLEOSTINE10MGCAPSULE / ORALABRLD, Approved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N017588-002GLEOSTINE40MGCAPSULE / ORALABRLD, RS, Approved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N017588-003GLEOSTINE100MGCAPSULE / ORALABRLD, Approved before 1982a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N017588-004GLEOSTINE5MGCAPSULE / ORALRLD2014-12-19a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10N017588-001AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10N017588-002AB1d4dbc9d85df4…
2026-11-14 07:37:172026-10N017588-003AB1d4dbc9d85df4…
2026-10-15 13:18:302026-09N017588-001AB1c2088c7a36db…
2026-10-15 13:18:302026-09N017588-002AB1c2088c7a36db…
2026-10-15 13:18:302026-09N017588-003AB1c2088c7a36db…
2026-09-14 22:38:342026-08N017588-001AB184e616aacf4f…
2026-09-14 22:38:342026-08N017588-002AB184e616aacf4f…
2026-09-14 22:38:342026-08N017588-003AB184e616aacf4f…
2026-08-18 06:07:402026-07N017588-001AB1caaa826d4ba7…
2026-08-18 06:07:402026-07N017588-002AB1caaa826d4ba7…
2026-08-18 06:07:402026-07N017588-003AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N017588-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017588-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N017588-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017588-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017588-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N017588-003AB131067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N017588-001AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N017588-002AB1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N017588-003AB1a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LomustineLOMUSTINEWilshire Pharmaceuticals, Inc.3c3637fc-4499-4331-a3c4-6969fc86704e2026-02-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 017588
application number: NDA017588
GleostineLOMUSTINEAzurity Pharmaceuticals, Inc.3529fe2f-3c23-4862-bb20-b480269570822025-09-25Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 017588
application number: NDA017588
GleostineLOMUSTINENextSource Biotechnology, LLC7f77526b-4c40-409c-82ea-d0f934d89cc22024-01-23Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 017588
application number: NDA017588
ndc (product): 58181-3040
ndc (product): 58181-3042
ndc (product): 58181-3041

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 9 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
58181-3040GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3040GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3040GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3041GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3041GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3041GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3042GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3042GleostinelomustineNextSource Biotechnology, LLCNDACurrent
58181-3042GleostinelomustineNextSource Biotechnology, LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
64854SUPPL2020-10-06
63588SUPPL2020-06-17
33317SUPPL2016-02-02
13864SUPPL2016-02-01
11042SUPPL2016-01-07
661SUPPL2016-01-07
33316SUPPL2014-05-28
660SUPPL2014-05-22
11041SUPPL2013-08-21
11040SUPPL2012-11-28
658SUPPL2012-11-23
33315SUPPL2011-05-16
659SUPPL2011-05-16
33314SUPPL2009-05-11
657SUPPL2009-05-06
656SUPPL2003-03-10
655SUPPL2002-12-20